EGFR and non-small cell lung carcinoma: Multivariate logistic regression analysis revealed that only gender (EGFR-21-MT: OR =0.167, 95% CI [0.085-0.328], P < 0.001; EGFR-19-MT: OR =0.287, 95% CI [0.124-0.664], P < 0.001) and SUVmax (EGFR-21-MT: OR =1.186, 95% CI [1.122-1.253], P < 0.001; EGFR-19-MT: OR =1.330, 95% CI [1.241-1.424], P < 0.001) were independent predictors of EGFR mutation status and mutation site profiles in NSCLC patients in Supplementary Table 2.